Pharmacologically guided phase I clinical trials based upon preclinical drug development

Journal of the National Cancer Institute

Volumn 82, Issue 16, 1990, Pages 1321-1326

  Collins, Jerry M ^a   Grieshaber, Charles K ^b   Chabner, Bruce A ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBAMOYLIMIDAZOLIUM 5 OLATE; ACODAZOLE; AMONAFIDE; ANTINEOPLASTIC AGENT; BREQUINAR; CARBOPLATIN; CISPLATIN; CRISNATOL; DATELLIPTIUM CHLORIDE; DIDEMNIN B; MALOPEN; SPIROPLATIN; SULFONYLUREA;

DRUG DEVELOPMENT; HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

EID: 0025360796     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/82.16.1321     Document Type: Review

References (0)